Q3 2021 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Eris Lifesciences Q3 FY 2021 Results Conference Call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. V Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir.
Good afternoon, everyone. Am I audible?
Yes, sir. You are clear and audible.
Great. I'm Krishnakumar, and a hearty welcome to our Q3 conference call. I'm happy to share this quarter's highlights with you.
To begin with, I'm happy to report that the domestic pharmaceutical industry, which we refer to as the IPM, it has returned to more normalcy in terms of operations, and the market has registered a growth of 6.4% in Q3. This is in comparison to 1.1% growth last quarter and a negative 5.2% growth in Q1.
The growth for the month of December has been 8.5%. This growth has been led by chronic and subchronic therapies,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
